Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that it will host an investor event to discuss expected corporate and product milestones in 2020.
SOUTH SAN FRANCISCO, Calif., Dec. 23, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc., ® (Nasdaq: PTLA) today announced that it will host an investor event to discuss expected corporate and product milestones in 2020. The event is scheduled to take place on Tuesday, January 14, at 7 a.m. PT (10 a.m. ET) and will be simultaneously webcast. Portola will provide updates on Andexxa® and Ondexxya® and its investigational hematologic compound, the oral SYK/JAK inhibitor cerdulatinib. Webcast Details About Portola Pharmaceuticals, Inc. View original content to download multimedia:http://www.prnewswire.com/news-releases/portola-pharmaceuticals-to-webcast-corporate-update-on-january-14-2020-300978499.html SOURCE Portola Pharmaceuticals, Inc.® | ||
Company Codes: NASDAQ-NMS:PTLA |